Lung cancer - (AFX UK Focus) 2006-06-05 07:09 GMT: Sanofi-Aventis says analysis shows Taxotere outperformed rival lung cancer drug

(AFX UK Focus) 2006-06-05 07:09 GMT: Sanofi-Aventis says analysis shows Taxotere outperformed rival lung cancer drug
Interactive Investor - Jun 04 11:35 PM
PARIS (AFX) - Sanofi-Aventis said a combined analysis of seven patient trials showed lung cancer patients treated with its Taxotere anti-cancer drug had better survival and toxicity results than those treated with an alternative class of medication known as vinca alkaloid drugs.Save to My Web